Alex Philippidis Reviews Trends in Biopharma & Biotech Market | CRISPR Cuts
apaperaday: Pfizer Eyes Resuming Phase III Enrollment, Investigates Phase Ib Death Tied to Duchenne Muscular Dystrophy Candidate • World Duchenne
From IT to Biotech: Sujal Patel Discusses the Promise of the Proteom
Mary Ann Liebert, Inc., publishers - We're just two days away! Join Genetic Engineering & Biotechnology News editors Alex Philippidis, Julianna LeMieux, PhD, and Kevin Davies, PhD, in a live fireside chat
25 Up-and-Coming Gene Therapies
Alex Philippidis on LinkedIn: #biotech #pharma
Alex Philippidis on LinkedIn: 20September: Ready for action In Rockville MD at BioHealth Capital Region…
Alex Philippidis (@AlexWestchester) / X
Alex Philippidis – BioHealth Capital Region
Despite Rocky Biotech Bear Market, the BioHealth Capital Region Holds Fast and Forges Ahead | BioBuzz